Sirolimus-based graft-versus-host disease prophylaxis

被引：0
|
作者：
Ruggeri, Annalisa [1 ,2 ]
机构：
[1] Osped Pediat Bambino Gesu, IRCCS, Dept Pediat Hematol & Oncol, I-00165 Rome, Italy
[2] Hop St Louis, Eurocord, Paris, France
来源：
LANCET HAEMATOLOGY | 2019年 / 6卷 / 08期
关键词：
CELL TRANSPLANTATION; RAPAMYCIN; GVHD;
D O I：
10.1016/S2352-3026(19)30108-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E387 / E388
页数：2
相关论文
共 50 条
  • [1] Thrombotic Microangiopathy Associated with Sirolimus Level after Allogeneic Hematopoietic Cell Transplantation with Tacrolimus/Sirolimus-Based Graft-versus-Host Disease Prophylaxis
    Shayani, Sepideh
    Palmer, Joycelynne
    Stiller, Tracey
    Liu, Xueli
    Thomas, Sandra H.
    Khuu, Tam
    Parker, Pablo M.
    Khaled, Samer K.
    Forman, Stephen J.
    Nakamura, Ryotaro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : 298 - 304
  • [2] Sirolimus immunosuppression for graft-versus-host disease prophylaxis and therapy: an update
    Cutler, Corey
    Antin, Joseph H.
    CURRENT OPINION IN HEMATOLOGY, 2010, 17 (06) : 500 - 504
  • [3] Sirolimus-Containing Graft-Versus-Host Disease Prophylaxis in Patients With Lymphoma
    Mehta, Jayesh
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) : E138 - E138
  • [4] Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis
    Marty, Francisco M.
    Bryar, Julie
    Browne, Sarah K.
    Schwarzberg, Talya
    Ho, Vincent T.
    Bassett, Ingrid V.
    Koreth, John
    Alyea, Edwin P.
    Soiffer, Robert J.
    Cutler, Corey S.
    Antin, Joseph H.
    Baden, Lindsey R.
    BLOOD, 2007, 110 (02) : 490 - 500
  • [5] Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant
    Greco, Raffaella
    Lorentino, Francesca
    Albanese, Serena
    Stanghellini, Maria Teresa Lupo
    Giglio, Fabio
    Piemontese, Simona
    Clerici, Daniela
    Lazzari, Lorenzo
    Marcatti, Magda
    Mastaglio, Sara
    Xue, Elisabetta
    Farina, Francesca
    Pavesi, Francesca
    Assanelli, Andrea
    Carrabba, Matteo G.
    Marktel, Sarah
    Vago, Luca
    Bonini, Chiara
    Corti, Consuelo
    Bernardi, Massimo
    Ciceri, Fabio
    Peccatori, Jacopo
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (09): : 776.e1 - 776.e13
  • [6] Defining the Role of Sirolimus in the Management of Graft-versus-Host Disease: From Prophylaxis to Treatment
    Abouelnasr, Ahmed
    Roy, Jean
    Cohen, Sandra
    Kiss, Thomas
    Lachance, Silvy
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (01) : 12 - 21
  • [7] Sirolimus-Containing Graft-Versus-Host Disease Prophylaxis in Patients With Lymphoma Reply
    Armand, Philippe
    Kim, Haesook T.
    Cutler, Corey S.
    Ho, Vincent T.
    Koreth, John
    Alyea, Edwin P.
    LaCasce, Ann S.
    Jacobsen, Eric D.
    Fisher, David C.
    Brown, Jennifer R.
    Canellos, George P.
    Freedman, Arnold S.
    Soiffer, Robert J.
    Antin, Joseph H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) : E139 - E140
  • [8] The development of graft-versus-host disease prophylaxis
    Cutler, Corey
    HAEMATOLOGICA, 2023, 108 (03) : 657 - 658
  • [9] Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis
    Garming Legert, Karin
    Ringden, Olle
    Remberger, Mats
    Torlen, Johan
    Mattsson, Jonas
    Dahllof, Goran
    ORAL DISEASES, 2021, 27 (05) : 1217 - 1225
  • [10] Precision medicine in prophylaxis of graft-versus-host disease
    Science Foundation in China, 2016, (02) : 17 - 17
12345